Refine by
Hip Resurfacing Arthroplasty Articles & Analysis
9 news found
On-site booth will host interactive experiences including product trials, hands-on demonstrations, and education Today, Johnson & Johnson MedTech* announced that DePuy Synthes,** The Orthopaedics Company of Johnson & Johnson, has acquired CUPTIMIZE™ Hip-Spine Analysis, giving surgeons an easy-to-use tool to better understand and address the impact of abnormal motion between the ...
Saluda Medical Pty Limited (“Saluda Medical”), a global company on a mission to revolutionize the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies designed to treat debilitating neurological disorders, today announced long-term results of its double-blind Level 1 EVOKE randomized controlled trial (RCT) published online in ...
KiOmed Pharma, an innovative Belgian biotech company, has reported positive safety and efficacy outcomes following the treatment of nearly 80 patients suffering from Knee OsteoArthritis (OA). This European Healthcare Professional (HCP) survey yielded a global long-term improvement of OA symptoms and shows preliminary evidence of improved outcomes in patients with advanced stage OA. ‘This ...
Ortho Development Corporation (ODEV) hosted the bi-annual Utah Hip and Knee Arthroplasty Symposium (UHKAS) in Park City, Utah on April 14-17, 2021. Over 120 people, including more than 60 surgeons and healthcare providers from across the country gathered for three days of interactive learning and relationship building. To kick off the event, several surgeon attendees participated in a hands-on ...
OrthoGrid® Systems, Inc., a global medtech leader on a mission to digitally transform intraoperative musculoskeletal surgery, announces the launch of its new OrthoGrid Hip software application after receiving FDA clearance on February 18, 2021. The new OrthoGrid Hip is the latest version of OrthoGrid System’s patented, distortion-correcting, implant-agnostic, intraoperative-alignment ...
OrthoGrid® Systems, Inc., a global medtech leader on a mission to digitally transform intraoperative musculoskeletal surgery, announces the publication of new clinical data supporting the use of its analog and digital technology in the Journal of Arthroplasty (JOA). The article, entitled “Comparison of Component Placement Accuracy Using Two Intraoperative Fluoroscopic Grid Technologies ...
Norristown, PA (USA) June 25, 2020: Maxx Orthopedics, Inc., a rapidly expanding global orthopedics device company, announced today the commercial launch and first successful surgeries of its new Libertas® Taper Reduced Uncemented Femoral Stem, the latest addition to its hip system. The Libertas Taper Reduced Uncemented Femoral Stem (Libertas TR®) is a press fit, double tapered stem ...
Alkahest, Inc., a clinical stage biotechnology company focused on developing transformative therapies to treat age-related diseases, today announced the dosing of the first patient in AKST6021-211, a phase 2 clinical trial of its proprietary human plasma fraction, GRF6021, administered before and after primary hip or knee arthroplasty, to provide key insights into the immunomodulatory effects of ...
Withdrawn Rationale: This practice covers a method for the fatigue testing of metallic stemmed femoral components used in hip arthroplasty. The described method is intended to be used for evaluation in comparisons of various designs and materials used for stemmed femoral components used in the ...